Levesque DL - Search Results

1

5-Benzylbarbituric acid derivatives, potent and specific inhibitors of uridine phosphorylase.

Naguib FN, Levesque DL, Wang EC, Panzica RP, el Kouni MH. Naguib FN, et al. Among authors: levesque dl. Biochem Pharmacol. 1993 Oct 5;46(7):1273-83. doi: 10.1016/0006-2952(93)90477-e. Biochem Pharmacol. 1993. PMID: 8216379

2

Aminotetralin drugs and D3 receptor functions. What may partially selective D3 receptor ligands tell us about dopamine D3 receptor functions?

Lévesque D. Lévesque D. Biochem Pharmacol. 1996 Aug 23;52(4):511-8. doi: 10.1016/0006-2952(96)00239-0. Biochem Pharmacol. 1996. PMID: 8759022 Review.

3

Modulation by estradiol and progesterone of the GTP effect on striatal D-2 dopamine receptors.

Lévesque D, Di Paolo T. Lévesque D, et al. Biochem Pharmacol. 1993 Feb 9;45(3):723-33. doi: 10.1016/0006-2952(93)90148-p. Biochem Pharmacol. 1993. PMID: 8095140

4

The antisense strategy applied to the study of dopamine D3 receptor functions in rat forebrain.

Tremblay M, Rouillard C, Lévesque D. Tremblay M, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1998 Jul;22(5):857-82. doi: 10.1016/s0278-5846(98)00045-1. Prog Neuropsychopharmacol Biol Psychiatry. 1998. PMID: 9723125

5

Calcium-dependent, D2 receptor-independent induction of c-fos by haloperidol in dopamine neurons.

Jomphe C, Lévesque D, Trudeau LE. Jomphe C, et al. Naunyn Schmiedebergs Arch Pharmacol. 2003 May;367(5):480-9. doi: 10.1007/s00210-003-0742-3. Epub 2003 Apr 15. Naunyn Schmiedebergs Arch Pharmacol. 2003. PMID: 12695877

6

Estrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain.

Landry M, Lévesque D, Di Paolo T. Landry M, et al. Neuroendocrinology. 2002 Oct;76(4):214-22. doi: 10.1159/000065951. Neuroendocrinology. 2002. PMID: 12411738

7

Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.

Morissette M, Lévesque D, Di Paolo T. Morissette M, et al. Mol Pharmacol. 1992 Sep;42(3):480-8. Mol Pharmacol. 1992. PMID: 1357544

8

Chronic estradiol treatment increases anterior pituitary but not striatal D2 dopamine receptor mRNA levels in rats.

Lévesque D, Gagné B, Barden N, Di Paolo T. Lévesque D, et al. Neurosci Lett. 1992 Jun 8;140(1):5-8. doi: 10.1016/0304-3940(92)90668-w. Neurosci Lett. 1992. PMID: 1407699

9

Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.

Lévesque D, Di Paolo T. Lévesque D, et al. Mol Pharmacol. 1991 May;39(5):659-65. Mol Pharmacol. 1991. PMID: 1674586

10

A physiological dose of estradiol with progesterone affects striatum biogenic amines.

Morissette M, Lévesque D, Bélanger A, Di Paolo T. Morissette M, et al. Can J Physiol Pharmacol. 1990 Dec;68(12):1520-6. doi: 10.1139/y90-231. Can J Physiol Pharmacol. 1990. PMID: 2085798

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters